Detalhe da pesquisa
1.
Novel read through agent: ZKN-0013 demonstrates efficacy in APCmin model of familial adenomatous polyposis.
J Mol Med (Berl)
; 101(4): 375-385, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36808265
2.
A Novel Class of Ribosome Modulating Agents Exploits Cancer Ribosome Heterogeneity to Selectively Target the CMS2 Subtype of Colorectal Cancer.
Cancer Res Commun
; 3(6): 969-979, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37377612